Deparment of Pharmaceuticals to organize a Felicitation Ceremony for winners of ‘Pharma & Medical Devices Startup Grand Challenge’ on 18th October 2021
The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, and Invest India are organizing a Felicitation Ceremony for the winning start-ups of the ‘Pharma & Medical Devices Startup Grand Challenge’ through a video conference on Monday, 18th of October, 2021 from 5:00 p.m. to 6:00 p.m. The felicitation ceremony shall have Shri Amitabh Kant, CEO, […]
Data up to 8-years for Roche’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
35% reduction in risk of needing a walking aid in relapsing multiple sclerosis (RMS) after 7.5 years vs. initiation 2 years later in Phase III open-label extension (OLE) 29% reduction in 48-week confirmed disability progression in primary progressive MS (PPMS) after 8 years vs. initiation after double-blind period in Phase III OLE New 8-year safety […]
Dr Bharati Pravin Pawar launches Phase II of Awareness Campaigns on HIV/AIDS & TB under ‘Azadi ka Amrit Mahotsav’
Dr Bharati Pravin Pawar, Union Minister of State for Health and Family Welfare launched Phase II of awareness campaigns on HIV/AIDS & TB under Azadi ka Amrit Mahotsav, here today. She also virtually interacted with students from across the country and encouraged them to contribute to nation building, as India commemorates 75th year of Independence. […]
Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) Gantenerumab is the first and only anti-amyloid antibody being investigated for subcutaneous administration in late-stage trials for the treatment of AD Ongoing Phase III GRADUATE programme with gantenerumab is anticipated to deliver a comprehensive data set with expected readout in the […]
Ebola virus disease – Democratic Republic of the Congo
On 8 October 2021, the Ministry of Health of the Democratic Republic of the Congo (DRC) announced that a new laboratory confirmed case of Ebola virus disease (EVD) had been detected in Butsili Health Area, Beni Health Zone in North Kivu Province. Earlier this year, an EVD outbreak affected North Kivu Province which was declared […]
New Ebola case in North Kivu in the Democratic Republic of the Congo
Brazzaville/Kinshasa, 8 October 2021 – The Ministry of Health of the Democratic Republic of the Congo today announced that a new case of Ebola has been detected in the health zone of Butsili in North Kivu Province, where a previous outbreak was declared over 3 May 2021. The Goma branch of the National Institute of […]
WHO report highlights global shortfall in investment in mental health
The World Health Organization’s new Mental Health Atlas paints a disappointing picture of a worldwide failure to provide people with the mental health services they need, at a time when the COVID-19 pandemic is highlighting a growing need for mental health support. The latest edition of the Atlas, which includes data from 171 countries, provides […]
Paving the path for Antyodaya of COVID-19 Vaccination: Quantitative Restriction on Export of Syringes Put in Place
The Domestic Vaccine Manufacturers and Manufacturers of Syringes have played an important and critical role in the effective implementation of World’s largest COVID Vaccination Program in India. India has so far administered nearly 94 Crore Vaccine doses and is nearing 100 Crore doses administration mark. With firm political commitment to vaccinate India’s last citizen, fulfilling […]
Dr. Mansukh Mandaviya distributes Green Ribbons to spread awareness on Mental Health
“Mental Health is an essential component of Holistic Health and awareness on it will go a long way to address the stigma surrounding it”. Dr. Mansukh Mandaviya, Union Minister for Health and Family Welfare stated this as he launched the Green Ribbon Initiative, here today. The event was organised by the Union Ministry of Health […]
Roche to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis optica spectrum disorder at ECTRIMS 2021
OCREVUS (ocrelizumab) data to show sustained reduction in disability progression through 8 years for primary progressive multiple sclerosis (PPMS) and 7.5 years for relapsing MS (RMS) Long-term safety analysis of all clinical trials will reinforce the consistently favourable benefit-risk profile of OCREVUS ENSPRYNG (satralizumab) data to show efficacy and safety sustained over four years of […]
